Cellectar Biosciences Inc Inc. (CLRB) Price Performance: The Role of Supply and Demand

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The index has shown a price gain of 19.31% this year. Over the last six months, there has been a weaker performance of 29.61%. The price of CLRB fallen by 3.28% during the last 30 days period. For the last 5-days stocks have improved 6.96%.

Cellectar Biosciences Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $4.45 on 03/04/24, and the lowest price during the same period was recorded at $1.56 on 08/11/23.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

52-week price history of CLRB Stock

The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Cellectar Biosciences Inc’s current trading price is -25.73% away from its 52-week high, while its distance from the 52-week low is 111.83%. The stock’s price range for this period has been between $1.56 and $4.45. The Healthcare sector company’s shares saw a trading volume of about 0.63 million for the day, which was lower than the average daily volume of 0.8 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Cellectar Biosciences Inc (CLRB) has experienced a quarterly decline of -17.37% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 118.48M and boasts a workforce of 20 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 3.49, with a change in price of -0.43. Similarly, Cellectar Biosciences Inc recorded 955,542 in trading volume during the last 100 days, posting a change of -11.76%.

CLRB’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for CLRB stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.02.

CLRB Stock Stochastic Average

As of today, the raw stochastic average of Cellectar Biosciences Inc over the last 50 days is at 30.32%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 63.13%. Further, the company’s Stochastic %K and %D values for the last 20 days were 41.81% and 27.42%, respectively.

Most Popular